Acta Medica Iranica

该期刊允许在有限且负责任的前提下使用人工智能辅助工具（如大语言模型、语法或语言润色软件）来支持稿件准备工作，例如提升语言清晰度、语法或格式。 模型中文摘要

Artificial intelligence (AI)–assisted tools (e.g., large language models, grammar or language-editing software) may be used in a limited and responsible manner to support manuscript preparation, such as improving language clarity, grammar, or formatting.

所有作者必须披露任何可能影响结果解读的财务或非财务利益冲突；如无利益冲突，也必须明确说明。 模型中文摘要

All authors must disclose any financial or non-financial conflicts of interest that could influence the interpretation of the results. If no conflicts exist, this must be explicitly stated.

作者必须提供数据可用性声明，说明支持研究结论的数据可在何处获取，或在适用情况下清楚说明数据受限的原因；该声明将作为最终发表文章的一部分予以发布，以促进透明度和可重复性。 模型中文摘要

Authors must include a Data Availability Statement specifying where the data supporting the findings of the study can be accessed or clearly stating the reasons for any data restrictions, if applicable. Data Availability Statements are published as part of the final article to promote transparency and reproducibility.

Acta Medica Iranica 遵循国际医学期刊编辑委员会（COPE）规定的出版伦理和最佳实践原则；所有涉嫌学术不端的行为，包括抄袭、数据造假、篡改、重复发表和不道德的研究行为，都将按照 COPE 指南进行调查和处理。 模型中文摘要

Acta Medica Iranica adheres to the principles of publication ethics and best practices as defined by the Committee on Publication Ethics (COPE). All cases of suspected misconduct, including plagiarism, data fabrication, falsification, duplicate publication, and unethical research practices, will be investigated and handled in accordance with COPE guidelines.

所有稿件均经过双盲同行评审流程。 模型中文摘要

All manuscripts undergo a double-blind peer review process.

临床试验必须在受试者招募前在公开可访问的注册库（如 ClinicalTrials.gov 或 WHO ICTRP）中注册，且注册号必须在稿件中提供。 模型中文摘要

Clinical trials must be registered in a publicly accessible registry (e.g., ClinicalTrials.gov or WHO ICTRP) prior to participant enrollment. The registration number must be provided in the manuscript.